stars 1 stars 2 stars 3

The current market requires both innovation and growth to drive the creation of new biologics. At ALLOZYNE, we demonstrate this through both of our technology platforms as well as across our pipeline to target key disease areas. Both of our platforms enable the incorporation of amino acid analogues at any position to create biologics that elicit improved efficacy, tolerability and pharmacology.

ALLOZYNE Questions

The ALLOZYNE annual revenue was $11 million in 2026.

Kenneth Grabstein is the Chief Scientific Officer of ALLOZYNE.

2 people are employed at ALLOZYNE.

ALLOZYNE is based in Seattle, Washington.

The NAICS codes for ALLOZYNE are [54, 5417, 541].

The SIC codes for ALLOZYNE are [87, 873].

Top ALLOZYNE Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users